Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Below is a comparative summary and then some focused profiles to assist in evaluating choices along dimensions of mechanism, expected results, and clinical relevance
Primary research: Sleep regulation, circadian rhythm, stress response Mechanism: Modulates sleep spindle activity and interacts with multiple neurotransmitter systems including GABA, serotonin, and glutamate Regulatory status: Not FDA-approved
It is an investigational compound, not an FDA-approved medication
A 30-year-old likely has far fewer senescent cells than a 60-year-old, which means: Younger individuals may notice less from FOXO4-DRI simply because there are fewer target cells to clear Older individuals or those with conditions associated with accelerated senescence (chronic inflammation, metabolic syndrome, prior chemotherapy) may have more to gain and more pronounced initial side effects from a larger clearance event Overall Health and Immune Function The immune system must clear apoptotic cells after FOXO4-DRI triggers their death
GHK-Cu excels for skin and inflammatory conditions
